title: The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research.
abstract: OBJECTIVE
  The study aimed to examine attitudes of individuals diagnosed with sarcoma and their family members towards genetics, genomic research and incidental information arising as a result of participating in genetic research.
  
  
  METHODS
  A questionnaire was administered to 1200 individuals from the International Sarcoma Kindred Study (ISKS). Respondents were divided into three groups: individuals affected with sarcoma (probands), their spouses and family members.
  
  
  RESULTS
  Approximately half of all research participants felt positively towards new discoveries in human genetics. Overall, more were positive in their attitudes towards genetic testing for inherited conditions (60%) but family members were less so. Older participants reported more highly positive attitudes more often than younger participants. Males were less likely to feel positive about new genetic discoveries and more likely to believe they could modify genetic risk by altering lifestyle factors. Almost all ISKS participants believed participants would like to be given ancillary information arising as a result of participating in genetic research.
  
  
  CONCLUSIONS
  The only difference between the study groups was the decreased likelihood of family members being highly positive about genetic testing. This may be important if predictive testing for sarcoma becomes available. Generally ISKS research participants supported the notion of returning incidental genetic information to research participants.
authors.affiliation: Department of Oncology, University of Melbourne, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, Victoria 8006, Australia. mary-anne.young@petermac.org.
authors.forename: Mary-Anne
authors.initials: MA
authors.lastname: Young
authors.forename: Amy
authors.initials: A
authors.lastname: Herlihy
authors.forename: Gillian
authors.initials: G
authors.lastname: Mitchell
authors.forename: David M
authors.initials: DM
authors.lastname: Thomas
authors.forename: Mandy
authors.initials: M
authors.lastname: Ballinger
authors.forename: Kathy
authors.initials: K
authors.lastname: Tucker
authors.forename: Craig R
authors.initials: CR
authors.lastname: Lewis
authors.forename: Susan
authors.initials: S
authors.lastname: Neuhaus
authors.forename: Jane
authors.initials: J
authors.lastname: Halliday
references.citation: Genet Med. 2008 Nov;10(11):831-9
references.pmid: 19011407
references.citation: Am J Bioeth. 2008 Nov;8(11):36-43
references.pmid: 19061108
references.citation: Am J Med Genet. 2000 Aug 14;93(4):257-63
references.pmid: 10946349
references.citation: Am J Med Genet A. 2012 Oct;158A(10):2519-25
references.pmid: 22903777
references.citation: Genet Med. 2011 Aug;13(8):723-8
references.pmid: 21633294
references.citation: Genet Med. 2012 Apr;14(4):405-10
references.pmid: 22422049
references.citation: J Community Genet. 2014 Jan;5(1):59-68
references.pmid: 22477021
references.citation: Genet Med. 2012 Apr;14(4):355-7
references.pmid: 22481182
references.citation: Nat Rev Cancer. 2008 Apr;8(4):288-98
references.pmid: 18354417
references.citation: J Med Ethics. 2011 May;37(5):271-5
references.pmid: 21345860
references.citation: J Empir Res Hum Res Ethics. 2009 Sep;4(3):99-111
references.pmid: 19754239
references.citation: Clin Sarcoma Res. 2012 Jan 09;2(1):1
references.pmid: 22588051
references.citation: J Health Commun. 2000 Jan-Mar;5(1):29-39
references.pmid: 10848030
references.citation: Genet Med. 2010 Jun;12(6):342-3
references.pmid: 20556868
references.citation: Genet Med. 2012 Apr;14(4):361-84
references.pmid: 22436882
references.citation: Arch Intern Med. 2002 Jul 8;162(13):1457-62
references.pmid: 12090881
references.citation: Br J Nurs. 2004 May 13-26;13(9):540-5
references.pmid: 15215731
references.citation: J Genet Couns. 2005 Feb;14(1):55-69
references.pmid: 15789156
references.citation: Genet Med. 2012 Apr;14(4):451-7
references.pmid: 22402755
references.citation: Mayo Clin Proc. 2007 Nov;82(11):1409-32
references.pmid: 17976362
references.citation: Genet Test Mol Biomarkers. 2012 Mar;16(3):193-7
references.pmid: 22047505
references.citation: Annu Rev Pathol. 2011;6:479-507
references.pmid: 21090969
references.citation: Genet Med. 2012 Mar;14(3):293-5
references.pmid: 22391780
references.citation: Genet Test Mol Biomarkers. 2011 Dec;15(12):871-5
references.pmid: 21749214
references.citation: N Engl J Med. 2011 Feb 10;364(6):524-34
references.pmid: 21226570
references.citation: Clin Genet. 1992 Apr;41(4):189-96
references.pmid: 1576756
references.citation: Br J Cancer. 2000 Jun;82(12):1932-7
references.pmid: 10864200
references.citation: Public Underst Sci. 2010 Mar;19(2):166-80
references.pmid: 20533796
references.citation: JAMA. 2002 Jul 17;288(3):363-5
references.pmid: 12117402
references.citation: Genet Test Mol Biomarkers. 2012 Jun;16(6):508-13
references.pmid: 22352737
references.citation: Patient Educ Couns. 1997 Sep-Oct;32(1-2):41-9
references.pmid: 9355571
references.citation: Med J Aust. 2006 Jan 16;184(2):81-3
references.pmid: 16411874